Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategies.
Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategies.
复制标题
DOI:
10.1126/scitranslmed.aaw0682
复制
发表时间:
2021-02-10
影响因子:
17.1
通讯作者:
Morrow EM
中科院分区:
文献类型:
--
作者:
Lizarraga SB;Ma L;Maguire AM;van Dyck LI;Wu Q;Ouyang Q;Kavanaugh BC;Nagda D;Livi LL;Pescosolido MF;Schmidt M;Alabi S;Cowen MH;Brito-Vargas P;Hoffman-Kim D;Gamsiz Uzun ED;Schlessinger A;Jones RN;Morrow EM
Christianson syndrome (CS), an X-linked neurological disorder characterized by postnatal attenuation of brain growth (postnatal microcephaly), is caused by mutations in SLC9A6 (also termed NHE6), the gene encoding endosomal Na+/H+ exchanger 6 (NHE6). To hasten treatment development, we established CS patient-derived induced pluripotent stem cell (iPSC) lines representing a mutational spectrum, as well as biologically related and isogenic control lines. We demonstrated that pathogenic mutations lead to loss of protein function by a variety of mechanisms: the majority of mutations caused loss of mRNA due to nonsense-mediated mRNA decay; however, a recurrent, missense mutation (the G383D mutation) had both loss-of-function and dominant-negative activities. Regardless of mutation, all patient-derived neurons demonstrated reduced neurite growth and arborization, likely underlying diminished postnatal brain growth in patients. Phenotype rescue strategies showed mutation-specific responses: a gene transfer strategy was effective in nonsense mutations, but not in the G383D mutation, wherein residual protein appeared to interfere with rescue. In contrast, application of exogenous trophic factors (BDNF or IGF-1) rescued arborization phenotypes across all mutations. These results may guide treatment development in CS, including gene therapy strategies wherein our data suggest that response to treatment may be dictated by the class of mutation. Neurons from patient-derived iPSCs demonstrate mutation-specific responses to potential therapeutic strategies for Christianson syndrome.
登录
查看更多内容
影响因子:
3
作者:
Langfelder P;Horvath S
通讯作者:
Horvath S
影响因子:
5.8
作者:
Glaser, F;Pupko, T;Ben-Tal, N
通讯作者:
Ben-Tal, N
影响因子:
7.8
作者:
Galli, T;Chilcote, T;Mundigl, O;Binz, T;Niemann, H;De Camilli, P
通讯作者:
De Camilli, P
影响因子:
4
作者:
Christianson, AL;Stevenson, RE;Schwartz, CE
通讯作者:
Schwartz, CE
DOI:
10.1073/pnas.1311141111
发表时间:
2014-03-25
影响因子:
11.1
作者:
Khwaja, Omar S.;Ho, Eugenia;Kaufmann, Walter E.
通讯作者:
Kaufmann, Walter E.